<DOC>
	<DOCNO>NCT00003104</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-ray kill tumor cell . Computer system allow doctor create 3-dimensional picture tumor order plan treatment may result effective radiation therapy . PURPOSE : This phase II trial study well radiation therapy plan computer work treat patient prostate cancer .</brief_summary>
	<brief_title>Computer Planned Radiation Therapy Treating Patients With Prostate Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Establish efficacy high-dose three-dimensional conformal radiotherapy patient intermediate prognostic risk adenocarcinoma prostate . - Determine PSA relapse-free survival rate patient population . OUTLINE : Patients receive high-dose three-dimensional conformal radiotherapy 4-5 day per week least 9 week . Patients evaluate least weekly radiotherapy 2 4 month treatment completion . Thereafter , patient follow every 6 month total 3 year . PROJECTED ACCRUAL : A total 50 patient accrue study .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven intermediate prognostic risk ( T1T2 ) adenocarcinoma prostate Previously untreated ( except hormonal therapy ) PSA level great 10 ng/mL Gleason score great 6 OR PSA level great 10 ng/mL Gleason score least 7 Patients require volume reduction prostate prior radiotherapy continue treat least 3 month neoadjuvant hormonal therapy prior radiation No evidence distant metastases No regional lymph node involvement PATIENT CHARACTERISTICS : Age : Not specify Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : No major medical illness No psychosis No metallic pelvic prosthesis PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy Endocrine therapy : See Disease Characteristics Prior neoadjuvant antiandrogen therapy allow Radiotherapy : No prior radiotherapy No prior pelvic irradiation Surgery : No prior radical surgery carcinoma prostate</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>adenocarcinoma prostate</keyword>
	<keyword>stage IIB prostate cancer</keyword>
	<keyword>stage IIA prostate cancer</keyword>
</DOC>